NCT07507006 Feasibility Study of the Flash-Sole: A Wearable Midsole With Soft Actuators for Walking Assistance
| NCT ID | NCT07507006 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Nebraska |
| Condition | Motor Function |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2028-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2025-07-01 with a primary completion date of 2028-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to test a new shoe device called Flash-Sole. The Flash-Sole is designed to help support the ankle while walking. It was developed by researchers at the University of Nebraska at Omaha. The device uses soft materials and electrical signals to gently assist with foot movement. The main questions this study aims to answer are: * Is the Flash-Sole safe to wear? * Is it comfortable for users? * Does it work as intended to assist walking? This study will include up to 15 healthy adults between the ages of 19 and 45. The Flash-Sole is considered investigational and is not approved by the U.S. Food and Drug Administration (FDA). Participants will: * Complete one visit at the Biomechanics Research Building that lasts about 2 hours * Answer a few health questions to make sure they can join the study * Do short walking trials wearing their own shoes * Wear special shoes with the Flash-Sole device * Walk short distances on a treadmill at a comfortable speed while the device is turned on and off * Wear small, sticky sensors on their legs to measure movement and muscle activity * Wear a safety harness to prevent falls * Complete a short survey about how the shoes felt and how easy they were to use The purpose of this early study is to learn how the device performs and how people feel about wearing it. The results may help guide improvements to the device and inform future studies. This research is not testing whether the device helps people with walking problems yet, but it may lead to that kind of research in the future.
Eligibility Criteria
Inclusion Criteria: 1. Age: 19 to 45 years old at the time of consent 2. Able to understand study procedures and provide informed consent 3. Able to walk independently without assistive devices 4. Willing to wear the Flash-Sole device and complete gait trials during a single session 5. Body weight under 80 kg to comply with device safety specifications Exclusion Criteria: 1. Current or recent (within 6 months) lower-limb injury, surgery, or fracture 2. History of neurologic, musculoskeletal, or cardiovascular conditions affecting gait 3. Skin conditions, open wounds, or known allergies at the foot/ankle that interfere with device wear 4. Use of implanted electronic medical devices (e.g., pacemakers, neurostimulators) 5. Cognitive or language impairments that preclude informed consent or task participation 6. no medication related to musculoskeletal condition (e.g., pain relief medications or similar treatments) .
Contact & Investigator
Ahad Behboo
PRINCIPAL INVESTIGATOR
University of Nebraska
Frequently Asked Questions
Who can join the NCT07507006 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, up to 45 Years, studying Motor Function. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07507006 currently recruiting?
Yes, NCT07507006 is actively recruiting participants. Contact the research team at smohammadi@unomaha.edu for enrollment information.
Where is the NCT07507006 trial being conducted?
This trial is being conducted at Omaha, United States.
Who is sponsoring the NCT07507006 clinical trial?
NCT07507006 is sponsored by University of Nebraska. The principal investigator is Ahad Behboo at University of Nebraska. The trial plans to enroll 10 participants.